Description
Infectious virus preparation designed to meet research and product development needs.
SARS-Related Coronavirus 2 Lineage B.1.1.7; Alpha Variant (Isolate: England/204820464/2020) is an enveloped, positive-sense single-stranded RNA virus from the Coronaviridae family and the Betacoronaviridae genus. Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), isolate hCoV19/England/204820464/2020 (also referred to as UK/VUI/3/2020 and VUI-202012/01) was isolated from a 58-year-old human male on November 24, 2020 in England, United Kingdom. Under the nomenclature system introduced by GISAID (Global Initiative on Sharing All Influenza Data), SARS-CoV-2, isolate hCoV19/England/204820464/2020 is assigned lineage B.1.1.7 and GISAID clade GR using Phylogenetic Assignment of Named Global Outbreak LINeages (PANGOLIN) tool. The complete genome of the clinical isolate of SARSCoV-2, isolate hCoV-19/England/204820464/2020 has been sequenced (GISAID: EPI_ISL_683466). Each frozen aliquot contains 1 mL of heat inactivated viral culture fluid. The pre-inactivation titer was determined from an infectious aliquot. Viral inactivation is verified after heat inactivation by the absence of viral growth in tissue culture-based infectivity assays.
Biosafety Level | 2 |
Certifications/Compliance | ISO 13485 |
Content And Storage | Store at -65°C or below |
Type | Infectious Culture Fluid |
For Use With (Application) | Nucleic Acid-Molecular Testing, Limit of Detection (LOD) Studies, Cross-reactivity Studies, Other Viral-based Assays |
Quantity | 1 mL |
Regulatory Status | RUO |